Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621539 | SCV000736003 | likely benign | Cardiovascular phenotype | 2015-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000631742 | SCV000752831 | benign | Long QT syndrome | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001201295 | SCV001372425 | benign | not specified | 2020-06-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001563480 | SCV001786431 | likely benign | not provided | 2019-11-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253534 | SCV002524814 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing |